Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS. jnnp.bmj.com/content/earl... #hvhebron #nimm #mprev [Text complet]
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS
Background The effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis (MS) declines with age, while treatment-related adverse events increase. Although discontinuation is increasing...
jnnp.bmj.com
September 16, 2026 at 8:30 PM
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS. jnnp.bmj.com/content/earl... #hvhebron #nimm #mprev [Text complet]
Persistent vaccine-type invasive pneumococcal disease in children despite high PCV13 coverage: the role of serotype 3 www.sciencedirect.com/science/arti... #hvhebron #mprev
www.sciencedirect.com
August 5, 2026 at 10:52 AM
Persistent vaccine-type invasive pneumococcal disease in children despite high PCV13 coverage: the role of serotype 3 www.sciencedirect.com/science/arti... #hvhebron #mprev
Rubella immunity and vaccination coverage among medical students in Catalonia: a multicentre seroprevalence study www.sciencedirect.com/science/arti... #hvhebron #mprev [Text complet]
Rubella immunity and vaccination coverage among medical students in Catalonia: a multicentre seroprevalence study
Rubella is a vaccine-preventable exanthematous viral infection whose most severe complication is congenital rubella syndrome. In countries such as Spa…
www.sciencedirect.com
August 5, 2026 at 10:55 AM
Rubella immunity and vaccination coverage among medical students in Catalonia: a multicentre seroprevalence study www.sciencedirect.com/science/arti... #hvhebron #mprev [Text complet]
Assessing Progression Independent of Relapse Activity in #Multiple #Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes onlinelibrary.wiley.com/doi/10.1002/... #hvhebron #nimm #mprev #rad [Text complet]
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient‐Reported Disability Measure and Self‐Administered Neuroperformance Outcomes
Objective
The objective of this study was to investigate the ability of patient-reported/administered outcomes to capture disability worsening and progression independent of relapse activity (PIRA) .....
onlinelibrary.wiley.com
July 10, 2026 at 9:29 AM
Assessing Progression Independent of Relapse Activity in #Multiple #Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes onlinelibrary.wiley.com/doi/10.1002/... #hvhebron #nimm #mprev #rad [Text complet]
SARS-CoV-2 seroprevalence in Barcelona and Catalonia (Spain) after the 2020 lockdown www.nature.com/articles/s41... #hvhebron #micro #bio #mprev [Text complet]
SARS-CoV-2 seroprevalence in Barcelona and Catalonia (Spain) after the 2020 lockdown - Scientific Reports
Scientific Reports - SARS-CoV-2 seroprevalence in Barcelona and Catalonia (Spain) after the 2020 lockdown
www.nature.com
June 26, 2026 at 9:30 AM
SARS-CoV-2 seroprevalence in Barcelona and Catalonia (Spain) after the 2020 lockdown www.nature.com/articles/s41... #hvhebron #micro #bio #mprev [Text complet]
Emerging reservoirs of metallo-β-lactamase genes among non- aeruginosa Pseudomonas and Stutzerimonas species in a Spanish tertiary hospital www.frontiersin.org/journals/mic... #hvhebron #micro #mintens #mprev #malinf [Text complet]
Frontiers | Emerging reservoirs of metallo-β-lactamase genes among non-aeruginosa Pseudomonas and Stutzerimonas species in a Spanish tertiary hospital
IntroductionPseudomonas is one of the largest genera among Gram-negative bacteria, currently comprising nearly 400 valid species. Among them, non-aeruginosa ...
www.frontiersin.org
June 18, 2026 at 11:40 AM
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity jamanetwork.com/journals/jam... #hvhebron #nimm #mprev #micro [Text complet]
Live Attenuated MMR and Varicella Vaccinations and Multiple Sclerosis Activity
This cohort study assesses whether measles-mumps-rubella (MMR) and varicella vaccinations are associated with risk of postvaccination relapse of multiple sclerosis.
jamanetwork.com
May 29, 2026 at 8:56 AM
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity jamanetwork.com/journals/jam... #hvhebron #nimm #mprev #micro [Text complet]
Emerging reservoirs of metallo- upbeta-lactamase genes among non-aeruginosa Pseudomonas and Stutzerimonas species in a Spanish tertiary hospital www.frontiersin.org/journals/mic... #hvhebron #micro #mintens #malinf #mprev [Text complet]
Frontiers | Emerging reservoirs of metallo- upbeta-lactamase genes among non-aeruginosa Pseudomonas and Stutzerimonas species in a Spanish tertiary hospital
IntroductionPseudomonas is one of the largest genera among Gram-negative bacteria, currently comprising nearly 400 valid species. Among them, non-aeruginosa ...
www.frontiersin.org
May 29, 2026 at 7:30 AM
Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study link.springer.com/article/10.1... #hvhebron #mprev [Text complet]
Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study - Journal of Epidemiology and Global ...
Journal of Epidemiology and Global Health - Immunocompromised individuals are at substantially increased risk of severe acute respiratory infection (SARI), often compounded by inadequate response...
link.springer.com
March 12, 2026 at 11:38 AM
Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study link.springer.com/article/10.1... #hvhebron #mprev [Text complet]
Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria www.sciencedirect.com/science/arti... #hvhebron #farm #mprev [Text complet]
Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria
Introduction: In July 2021, the European Medicines Agency issued a warning about reports of Guillain-Barré syndrome (GBS) following COVID-19 vaccinati…
www.sciencedirect.com
March 12, 2026 at 10:02 AM
Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria www.sciencedirect.com/science/arti... #hvhebron #farm #mprev [Text complet]
Infecciones de transmisión sexual en gestantes: prevalencia, coinfección y complicaciones del embarazo www.sciencedirect.com/science/arti... #hvhebron #mprev
Infecciones de transmisión sexual en gestantes: prevalencia, coinfección y complicaciones del embarazo
Las infecciones de transmisión sexual (ITS) durante el embarazo pueden generar complicaciones materno-fetales relevantes. El papel de otros microorgan…
www.sciencedirect.com
February 25, 2026 at 12:03 PM
Infecciones de transmisión sexual en gestantes: prevalencia, coinfección y complicaciones del embarazo www.sciencedirect.com/science/arti... #hvhebron #mprev
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform journals.plos.org/plosone/arti... #hvhebron #micro #mprev #nimm [Text complet]
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Background While multiple studies report that the BNT162b2 XBB.1.5-adapted mRNA COVID-19 vaccine (BNT162b2 XBB vaccine) is effective in preventing COVID-19 hospitalisation and death, effectiveness bey...
journals.plos.org
February 18, 2026 at 11:30 AM
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform journals.plos.org/plosone/arti... #hvhebron #micro #mprev #nimm [Text complet]
Exhausted/Senescent CD4+ T cells as Predictors of Vaccine Failure and Severe COVID-19 in Solid Organ Transplant Recipients www.sciencedirect.com/science/arti... #hvhebron #nefro #tras #micro #hepato #chbpt #malinf #nefroped #mprev
Exhausted/Senescent CD4+ T cells as Predictors of Vaccine Failure and Severe COVID-19 in Solid Organ Transplant Recipients
Despite booster vaccinations, solid organ transplants (SOT) develop suboptimal immunity and remain at risk of severe COVID-19. Chronic immunosuppressi…
www.sciencedirect.com
January 21, 2026 at 10:36 AM
Clusters of Comorbidities in #Multiple #Sclerosis and Their Influence on Healthcare Resource Usage onlinelibrary.wiley.com/doi/10.1111/... #hvhebron #nimm #mprev [Text complet]
Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage
Using latent-class models in a population-based sample of MS patients, cardiovascular and psychiatric clusters were identified. Nurse visits and medication dispensation were higher in the cardiovascu...
onlinelibrary.wiley.com
November 6, 2025 at 3:10 PM
Clusters of Comorbidities in #Multiple #Sclerosis and Their Influence on Healthcare Resource Usage onlinelibrary.wiley.com/doi/10.1111/... #hvhebron #nimm #mprev [Text complet]
Risk factors of COVID-19 breakthrough infection: a case-control test-negative design study bmcinfectdis.biomedcentral.com/articles/10.... #hvhebron #mprev #micro #malinf [Text complet]
Risk factors of COVID-19 breakthrough infection: a case-control test-negative design study - BMC Infectious Diseases
Background We aimed to identify risk factors for breakthrough SARS-CoV-2 infection after at least one dose of any COVID-19 vaccine. Methods This is a case-control test-negative design study in hospita...
bmcinfectdis.biomedcentral.com
October 23, 2025 at 2:45 PM
Risk factors of COVID-19 breakthrough infection: a case-control test-negative design study bmcinfectdis.biomedcentral.com/articles/10.... #hvhebron #mprev #micro #malinf [Text complet]
Safety monitoring of GSK’s quadrivalent seasonal influenza vaccine in European countries during the 2023/24 flu season: A multicenter, non-interventional study www.tandfonline.com/doi/full/10.... #hvhebron #mprev [Text complet]
www.tandfonline.com
October 23, 2025 at 2:32 PM
Safety monitoring of GSK’s quadrivalent seasonal influenza vaccine in European countries during the 2023/24 flu season: A multicenter, non-interventional study www.tandfonline.com/doi/full/10.... #hvhebron #mprev [Text complet]
Community-based strategies for tuberculosis control in migrant communities: how to integrate determinants of vulnerability into decision-making bmcpublichealth.biomedcentral.com/articles/10.... #malinf #mprev [Text complet]
bmcpublichealth.biomedcentral.com
October 16, 2025 at 1:59 PM
Community-based strategies for tuberculosis control in migrant communities: how to integrate determinants of vulnerability into decision-making bmcpublichealth.biomedcentral.com/articles/10.... #malinf #mprev [Text complet]
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort www.nature.com/articles/s41... #hvhebron #mprev
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort - British Journal of Cancer
British Journal of Cancer - Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort
www.nature.com
October 9, 2025 at 2:32 PM
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort www.nature.com/articles/s41... #hvhebron #mprev
Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients www.mdpi.com/2073-4409/14... #hvhebron #ad #micro #mprev #imm [Text complet]
www.mdpi.com
August 27, 2025 at 8:44 AM
Infecciones por Mpox en pacientes vacunados. ¿Es necesaria una dosis de recuerdo? www.sciencedirect.com/science/arti... #hvhebron #malinf #mprev
Infecciones por Mpox en pacientes vacunados. ¿Es necesaria una dosis de recuerdo?
www.sciencedirect.com
August 7, 2025 at 9:41 AM
Infecciones por Mpox en pacientes vacunados. ¿Es necesaria una dosis de recuerdo? www.sciencedirect.com/science/arti... #hvhebron #malinf #mprev
#Morbilidad y uso de recursos de las personas incluidas en el programa de #atención #domiciliaria de la atención primaria www.sciencedirect.com/science/arti... #hvhebron #mprev [Text complet]
Morbilidad y uso de recursos de las personas incluidas en el programa de atención domiciliaria de la atención primaria
Describir el estado de salud y uso de recursos de las personas incluidas en el programa de atención domiciliaria (ATDOM) mediante el uso secundario de…
www.sciencedirect.com
June 25, 2025 at 8:43 AM
#Morbilidad y uso de recursos de las personas incluidas en el programa de #atención #domiciliaria de la atención primaria www.sciencedirect.com/science/arti... #hvhebron #mprev [Text complet]
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study www.sciencedirect.com/science/arti... #hvhebron #malinf #micro #mprev
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study
Mpox is a viral illness for which the MVA-BN vaccine was authorized during the 2022 global outbreak. Although initial studies reported high immunogeni…
www.sciencedirect.com
May 29, 2025 at 10:24 AM
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study www.sciencedirect.com/science/arti... #hvhebron #malinf #micro #mprev
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study www.sciencedirect.com/science/arti... #hvhebron #malinf #micro #mprev
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study
Mpox is a viral illness for which the MVA-BN vaccine was authorized during the 2022 global outbreak. Although initial studies reported high immunogeni…
www.sciencedirect.com
May 28, 2025 at 12:01 PM
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study www.sciencedirect.com/science/arti... #hvhebron #malinf #micro #mprev
Inmunización frente a Haemophilus influenzae tipo b fuera del calendario sistemático de vacunación www.sciencedirect.com/science/arti... #hvhebron #mprev
Inmunización frente a Haemophilus influenzae tipo b fuera del calendario sistemático de vacunación
La epidemiología de la enfermedad invasiva por Haemophilus influenzae (H. influenzae) se ha modificado drásticamente desde la introducción de las vacu…
www.sciencedirect.com
April 30, 2025 at 7:35 AM
Inmunización frente a Haemophilus influenzae tipo b fuera del calendario sistemático de vacunación www.sciencedirect.com/science/arti... #hvhebron #mprev
Tendencias seculares en infecciones articulares periprotésicas tras artroplastias primarias de cadera y rodilla: un estudio de cohorte de 15 años del Programa VINCat (2008-2022) www.sciencedirect.com/science/arti... #hvhebron #mprev
Secular trends in periprosthetic joint infections following primary hip and knee arthroplasties: A 15-year cohort study from the VINCat Program (2008–2022)
The VINCat program, established in Catalonia, Spain, in 2006, is a comprehensive infection prevention program for healthcare-associated infections. Th…
www.sciencedirect.com
April 25, 2025 at 9:30 AM
Tendencias seculares en infecciones articulares periprotésicas tras artroplastias primarias de cadera y rodilla: un estudio de cohorte de 15 años del Programa VINCat (2008-2022) www.sciencedirect.com/science/arti... #hvhebron #mprev